TNF and inflammatory bowel disease: Analyses were also done within the respective disease cohort to investigate the potential differences in diversity between IBD subtypes, following the Montreal classification for CD and UC (18) as well as the influence of medication (e.g., 5-ASA, thiopurine, anti-tumor necrosis factor [TNF]).